PRELUDE CAPITAL MANAGEMENT, LLC - LA JOLLA PHARMACEUTICAL CO ownership

LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 73 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q2 2016. The put-call ratio across all filers is 1.19 and the average weighting 0.5%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q1 2020$8,000
-91.2%
2,000
-55.6%
0.00%
-80.0%
Q3 2018$91,000
+56.9%
4,500
+125.0%
0.01%
+25.0%
Q2 2018$58,000
-95.3%
2,000
-95.1%
0.00%
-95.5%
Q1 2018$1,226,000
+286.8%
41,156
+288.4%
0.09%
+196.7%
Q1 2017$317,000
+637.2%
10,596
+488.7%
0.03%
+500.0%
Q3 2016$43,000
-12.2%
1,800
-40.8%
0.01%
-28.6%
Q2 2016$49,000
+512.5%
3,040
+913.3%
0.01%
+600.0%
Q4 2015$8,0003000.00%
Other shareholders
LA JOLLA PHARMACEUTICAL CO shareholders Q2 2016
NameSharesValueWeighting ↓
TANG KEVIN C 240,000$1,027,00095.09%
TANG CAPITAL MANAGEMENT LLC 10,049,224$43,011,0008.56%
RTW INVESTMENTS, LP 2,327,903$9,963,0000.15%
Boxer Capital, LLC 890,700$3,812,0000.13%
Tibra Equities Europe Ltd 72,600$311,0000.10%
WealthTrust Axiom LLC 25,400$108,0000.04%
GSA CAPITAL PARTNERS LLP 52,749$226,0000.02%
FIRST MIDWEST BANK TRUST DIVISION 34,231$147,0000.02%
HOLLENCREST CAPITAL MANAGEMENT 42,355$181,0000.02%
Summit Global Investments 48,500$208,0000.01%
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders